FDA Clears BMS’ Orencia In Juvenile Arthritis

Second indication comes with news of Repligen settlement.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet